2022
DOI: 10.1002/ccr3.5419
|View full text |Cite
|
Sign up to set email alerts
|

Metastatic insulinoma presenting after bariatric surgery in a patient diagnosed with MEN1

Abstract: Insulinomas are uncommon neuroendocrine tumors and metastatic disease is extremely rare. We report a patient with metastatic insulinoma associated with multiple endocrine neoplasia type 1 presenting with hypoglycemia following sleeve gastrectomy. Potential causes of hypoglycemia include dumping syndrome, noninsulinoma pancreatogenous hypoglycemia syndrome, and rarely insulinoma. MEN1‐associated insulinomas have a higher recurrence rate.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 35 publications
0
1
0
Order By: Relevance
“…Insulin resistance caused by the obesity as well as lack of awareness of symptoms of hypoglycemia by the patients, may contribute to the delay in the identification of the insulinoma. Patients often fail to recognize autonomic warning symptoms and the hypoglycemia is only detected through the presence of neuroglycopenic symptoms delaying the diagnosis of the insulinoma for up to 5 years [21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37].…”
Section: Discussionmentioning
confidence: 99%
“…Insulin resistance caused by the obesity as well as lack of awareness of symptoms of hypoglycemia by the patients, may contribute to the delay in the identification of the insulinoma. Patients often fail to recognize autonomic warning symptoms and the hypoglycemia is only detected through the presence of neuroglycopenic symptoms delaying the diagnosis of the insulinoma for up to 5 years [21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37].…”
Section: Discussionmentioning
confidence: 99%